Thromboembolism.
Fitzmaurice
David
D
Birmingham, UK.
Hobbs
Fd Richard
FR
McManus
Richard
R
D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use; D020000:Decision Support Systems, Clinical; D004359:Drug Therapy, Combination; D006495:Heparin, Low-Molecular-Weight / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D011655:Pulmonary Embolism / Q000188:drug therapy; D013923:Thromboembolism / Q000188:drug therapy*; D015912:Thrombolytic Therapy; D020246:Venous Thrombosis / Q000188:drug therapy; D014859:Warfarin / Q000009:adverse effects / Q000627:therapeutic use
D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight; D014859:Warfarin